Maite Formaglio
Overview
Explore the profile of Maite Formaglio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
554
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Verdurand M, Kaczorowski F, Dautricourt S, Desestret V, Formaglio M, Mollion H, et al.
Alzheimers Dement (Amst)
. 2025 Jan;
17(1):e70066.
PMID: 39822296
Introduction: Seed amplification assays (SAAs) demonstrate remarkable diagnostic performance in alpha-synucleinopathies. However, existing protocols lack accessibility in routine laboratories, mainly due to the requirement for in-house production of recombinant alpha-synuclein...
2.
Favier M, Formaglio M, Cosson A, Claude F, Fauret-Amsellem A, Clot F, et al.
J Neurol
. 2025 Jan;
272(2):155.
PMID: 39820807
Introduction: The MAPT gene encodes Tau, a protein mainly expressed by neurons. Tau protein plays an important role in cerebral microtubule polymerization and stabilization, in axonal transport and synaptic plasticity....
3.
Grangeon L, Boulouis G, Capron J, Bala F, Renard D, Raposo N, et al.
Neurology
. 2024 Jun;
103(2):e209548.
PMID: 38900992
Background And Objectives: Cerebral amyloid angiopathy-related inflammation (CAA-RI) and biopsy-positive primary angiitis of the CNS (BP-PACNS) have overlapping clinicoradiologic presentations. It is unknown whether clinical and radiologic features can differentiate...
4.
Nicolas G, Zarea A, Lacour M, Quenez O, Rousseau S, Richard A, et al.
Genet Med
. 2024 Jan;
26(5):101082.
PMID: 38281098
Purpose: To assess the likely pathogenic/pathogenic (LP/P) variants rates in Mendelian dementia genes and the moderate-to-strong risk factors rates in patients with Alzheimer disease (AD). Methods: We included 700 patients...
5.
Grangeon L, Cassinari K, Rousseau S, Croisile B, Formaglio M, Moreaud O, et al.
Neurol Genet
. 2021 Sep;
7(5):e609.
PMID: 34532568
Background And Objective: To report a triplication of the amyloid-β precursor protein () locus along with relative messenger RNA (mRNA) expression in a family with autosomal dominant early-onset cerebral amyloid...
6.
Escal J, Fourier A, Formaglio M, Zimmer L, Bernard E, Mollion H, et al.
J Neurol
. 2021 Jul;
269(3):1522-1529.
PMID: 34313819
Objective: The 'Frontotemporal dementia-Amyotrophic lateral sclerosis Spectrum' (FAS) encompasses different phenotypes, including cognitive disorders (frontotemporal dementia, FTD) and/or motor impairments (amyotrophic lateral sclerosis, ALS). The aim of this study was...
7.
Salloway S, Farlow M, McDade E, Clifford D, Wang G, Llibre-Guerra J, et al.
Nat Med
. 2021 Jun;
27(7):1187-1196.
PMID: 34155411
Dominantly inherited Alzheimer's disease (DIAD) causes predictable biological changes decades before the onset of clinical symptoms, enabling testing of interventions in the asymptomatic and symptomatic stages to delay or slow...
8.
Lardeux P, Fourier A, Peter E, Dorey A, Muniz-Castrillo S, Vogrig A, et al.
J Neurol
. 2021 Jun;
269(1):377-388.
PMID: 34104991
Objective: To compare CSF biomarkers' levels in patients suffering from anti-Leucine-rich Glioma-Inactivated 1 (LGI1) encephalitis to neurodegenerative [Alzheimer's disease (AD), Creutzfeldt-Jakob's disease (CJD)] and primary psychiatric (PSY) disorders. Methods: Patients...
9.
Lehingue E, Gueniat J, Jourdaa S, Hardouin J, Pallardy A, Courtemanche H, et al.
J Alzheimers Dis
. 2021 Jan;
79(4):1735-1745.
PMID: 33459637
Background: The frontal variant of Alzheimer's disease (fAD) is poorly understood and poorly defined. The diagnosis remains challenging. The main differential diagnosis is the behavioral variant of frontotemporal degeneration (bvFTD)....
10.
Laurens B, Planche V, Cubizolle S, Declerck L, Dupouy S, Formaglio M, et al.
J Alzheimers Dis
. 2019 Aug;
71(2):613-621.
PMID: 31424412
Background/objective: Performances on spatial decision eye-tracking tasks are known to be impaired in patients with moderate Alzheimer's disease (AD), but the clinical relevance of this deficit during earlier stages of...